Last checked at 31 Jan 2022 07:00
Feedback plc
Notice of Results
London, 31 January 2022: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist clinical communication company, will announce results for the half year ended 30 November 2021 on Thursday 10 February 2022.
Analyst Briefing, 9:30am, Thursday 10 February 2022
A briefing for Analysts will be held at 9:30am GMT on the day of the results.
Analysts interested in attending should contact Walbrook PR by emailing feedbackplc@walbrookpr.com or by calling 020 7933 8780.
Further information on Feedback and its products can be found on the Company's website: https://fbkmed.com/feedback-plc/reports-and-presentations/
-Ends-
Enquiries:
Feedback plc Tom Oakley, CEO Anesh Patel, CFO | +44 (0) 20 3997 7634 IR@fbk.com |
|
|
Panmure Gordon (UK) Limited (NOMAD and Broker) Emma Earl/Freddy Crossley (Corporate Finance) Rupert Dearden (Corporate Broking) | +44 (0)20 7886 2500 |
|
|
Walbrook PR Ltd | Tel: 020 7933 8780 or feedbackplc@walbrookpr.com |
Paul McManus/Nick Rome/Nicholas Johnson | 07980 541 893 or 07748 325 236 or 07884 664 686 |
About Feedback
Feedback plc is a specialist clinical communications business, with a mission to improve the efficiency and quality of communications for frontline clinicians and hospitals with a key focus on building solutions that enhance access to high quality patient data.
Feedback has developed a toolkit of clinical communications apps. Its core, regulatory approved product is Bleepa, a revolutionary medical imaging app enabling remote and secure communications between frontline clinicians and teams. CareLocker is an evolutionary GDPR compliant patient-centric cloud architecture - its proprietary technology enables an easy route to creation and mobilisation of individual healthcare records. Bleepa Box is a specialist tool to enable image transfer from remote settings to the Bleepa platform over mobile networks.
The Company has a number of growth opportunities domestically and internationally across a range of markets including the NHS, the veterinary market and private healthcare providers and its highly scalable Software as a Service ("SaaS")-based revenue model is expected to provide increasing levels of visibility as the Company grows its customer base.